The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...

DelveInsight's Inflammatory Bowel disease market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 30, 2025 ...

Galapagos (0JXZ – Research Report) received a Sell rating and a €22.00 price target from Barclays analyst Emily Field today. The company’s ...

Johnson & Johnson’s inflammatory disease drug Stelara has been approved in Europe for ulcerative colitis (UC), a new ... adding that “competition in the moderate to severe disease category ...

If you have ulcerative colitis, your diet may help you manage symptoms. Research has indicated that many people who have mild-to-moderate ulcerative colitis benefit from making changes to their ...

Eating a Mediterranean-style diet can help people manage IBD symptoms, and a new cookbook from Crohn's & Colitis Ireland ...

Biologics treat moderate-to-severe ulcerative colitis. They target and inhibit specific proteins involved in the body's inflammatory process. Biologic medication is delivered via subcutaneous ...

Cooney has worked for many years with Crohn’s & Colitis Ireland (CCI ... and olive oil, with moderate consumption of dairy products and minimal intake of red meat and processed foods, it ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

For detection of moderate-to-severe disease ... Pearson correlations for the Pediatric Ulcerative Colitis Activity Index and Pediatric Crohn's Disease Activity Index scores were 0.070 and −0 ...